Results 271 to 280 of about 63,333 (299)

Atypical Parkinsonian Disorders

Neurologic Clinics
Atypical parkinsonian disorders (APD) include progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy. Identifying APD is important because they have different pathogenesis, disease course, and prognosis than Parkinson's disease (PD), and require different treatments.
Nahid, Olfati, Fahimeh H, Akhoundi, Irene, Litvan   +2 more
openaire   +2 more sources

Serial volumetric MRI in Parkinsonian disorders

Movement Disorders, 2009
AbstractTracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra‐ and inter‐rater reliability.
Wild, E.J., Fox, N.C.I.
openaire   +4 more sources

The Role of Tau Imaging in Parkinsonian Disorders

Current Neurology and Neuroscience Reports, 2018
Differential diagnosis of atypical Parkinson syndromes (APS) is difficult as clinical presentations may vary and as there is a strong overlap between disease entities. Aggregations of misfolded and hyperphosphorylated tau proteins are the common denominator of many of these diseases.Several tau targeting positron emission tomography (PET) tracers have ...
Hammes, Jochen, Drzezga, Alexander, Eimeren, Thilo   +2 more
openaire   +4 more sources

Glabellar and palmomental reflexes in parkinsonian disorders

Neurology, 2004
The authors examined the glabellar reflex and the palmomental reflex in 100 subjects, including patients with Parkinson disease (n = 41), patients with progressive supranuclear palsy (n = 12), patients with multiple system atrophy (n = 7), and healthy, age-matched, controls (n = 40).
Harris Brodsky, Madhavi Thomas, Joseph Jankovic, Kevin Dat Vuong   +3 more
openaire   +2 more sources

Brain perfusion differences in Parkinsonian disorders

Movement Disorders, 2011
AbstractWe aimed to objectively examine the brain perfusion differences between PD, Parkinson variant of multiple system atrophy, and progressive supranuclear palsy. 99mTc ethylcysteinate dimer single‐photon emission CT (SPECT) was performed in 28 patients with PD, 12 with Parkinson variant of multiple system atrophy, 19 with progressive supranuclear ...
Yusuke Hazama, Syojirou Hanaki, Toshihide Kumamoto, Noriyuki Kimura, Ryuki Arakawa, Takuya Hanaoka, Teruaki Masuda, Toshio Okazaki   +7 more
openaire   +3 more sources

ATYPICAL PARKINSONIAN DISORDERS

Continuum, 2004
Atypical Parkinsonian disorders , Atypical Parkinsonian disorders , کتابخانه دیجیتال جندی شاپور ...
openaire   +2 more sources

The auditory startle reaction in parkinsonian disorders

Movement Disorders, 2001
The auditory startle reaction to an unexpected loud stimulus is regarded as a brainstem reflex originating in the nucleus reticularis pontis caudalis and being distributed up the brainstem and down the spinal cord along slowly conducting pathways. Auditory startle responses (ASR) have been reported absent or reduced in progressive supranuclear palsy ...
Markus Kofler, Sylvia Bösch, Laura Reggiani, Gerhard Ransmayr, Pia Hollosi, Josep Valls-Solé, Jörg Müller, Werner Poewe, Gregor K. Wenning   +8 more
openaire   +3 more sources

Update of atypical parkinsonian disorders

Current Opinion in Neurology, 2007
This timely update discusses novel diagnostic approaches, recently identified genes, and innovative experimental symptomatic treatments for these devastating disorders.Differential patterns in the basal ganglia transcranial sonography, magnetic resonance diffusion-weighted imaging regional apparent diffusion coefficients in the brainstem, basal ganglia
openaire   +3 more sources

Tracking the neurodegeneration of parkinsonian disorders – a pilot study

Neuroradiology, 2007
The purpose of the study was to explore the possibilities of using diffusion tensor imaging (DTI) and tractography (DTT) for the differential diagnosis and monitoring of disease progression in idiopathic Parkinson's disease (IPD), compared with the atypical parkinsonian disorders multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). A
Nilsson, C, Markenroth Bloch, K, Brockstedt, S, Latt, J, Widner, Widner H, Larsson, Elna Boel-Marie   +5 more
openaire   +4 more sources

Cerebrospinal Fluid Levels of Neurogranin in Parkinsonian Disorders

Movement Disorders, 2019
AbstractBackgroundCSF concentration of neurogranin has been suggested as a biomarker for synapse dysfunction.ObjectivesTo investigate CSF neurogranin in parkinsonian disorders compared to controls and Alzheimer's disease and the possible correlations between neurogranin and cognitive and motor impairment.MethodsWe included 157 patients with PD, 29 with
Henrik Zetterberg, Oskar Hansson, Britta Brix, Shorena Janelidze, Sara Hall, Kaj Blennow, Kaj Blennow, Yulia Surova, Niklas Mattsson   +8 more
openaire   +4 more sources